Search

Doctors and nurses with Memorial Sloan Kettering’s Plastic and Reconstructive Surgical Service have developed new, simplified models to better predict and prevent breast cancer-related lymphedema.

… Thursday, July 27, 2023 Doctors and nurses with  Memorial Sloan Kettering’s Plastic and Reconstructive Surgical Service have developed new, simplified models to better predict and prevent  breast cancer-related lymphedema, an uncomfortable side effect that develops in the months following surgery. Lymphedema

Learn about results from a clinical trial that found blood tests can help predict which patients with large B cell lymphoma are likely to benefit from the targeted therapy glofitamab (Columvi).

… Monday, December 11, 2023 There is encouraging news about using a blood test to determine which patients with aggressive large B cell  lymphoma were most likely to benefit from having the drug glofitamab (Columvi™) added to their treatment. Results from a phase 2 clinical trial (research study) were

Fighting cancer is often sobering and difficult work, but it is also full of hope. Ask anyone who works at MSK what inspires them, and they will tell you it’s the courage and resilience of the people they care for every day.

… Thursday, September 11, 2025 Dear MSK Community, If you ask the 21,000 people who work at MSK what inspires their tireless commitment to our mission of ending cancer for life, you will hear remarkable responses. Stories about the courage and resilience of the people we care for, an epiphany early in

… Friday, June 6, 2025 From the day Shakima Grant was hired as a care coordinator at MSK, in 2007, she says she knew she had found her purpose. “It always felt like I was meant to be here,” says Shakima, whose grandmother passed away from stage 4 ovarian cancer that very same year. Her grandmother lived

What's it like being LGBTQ in the world of science? We asked some MSK scientists to find out.

… Thursday, June 21, 2018 From left: Jason Lewis, Scott Keeney, Kat Hadjantonakis, Stefanie Windner, and Suleman Hussain. From left: Jason Lewis, Scott Keeney, Kat Hadjantonakis, Stefanie Windner, and Suleman Hussain. Photos by Rick DeWitt. They’re here. They’re queer. They’re scientists. In honor of Pride

The results of a large, international randomized trial herald a change in medical practice for the treatment of melanoma.

… Thursday, June 8, 2017 Summary A large study of nearly 2,000 people has answered an important question about the surgical treatment of melanoma , a type of skin cancer. For people with cancer detected in their sentinel lymph node, a watch-and-wait approach rather than immediate removal of all regional

GSK’s Fourth Biennial Retreat on May 6 and 7 at the Mohonk Mountain House in New Paltz, New York, will feature former Sloan Kettering Institute Director Dr. Thomas J. Kelly.

… Monday, May 2, 2016 The Gerstner Sloan Kettering Graduate School of Biomedical Sciences’ fourth Biennial Retreat will take place from May 6 through May 7, 2016, at the Mohonk Mountain House in New Paltz, New York. The retreat will celebrate the first decade of matriculants in GSK’s graduate program.

Memorial Sloan Kettering Cancer Center announced it has selected Epic to provide a new platform for integrated care that will ensure patients and physicians can more easily access electronic health records.

… Monday, November 21, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced it has selected Epic to provide a new platform for integrated care that will ensure patients and physicians can more easily access electronic health records (EHR). Implementing Epic is an important milestone that will

Memorial Sloan Kettering Cancer Center physician-scientists report that women with small, node-negative, HER2-positive breast cancer may obtain a significant benefit from adjuvant chemotherapy with trastuzumab (Herceptin®), a drug previously shown to improve outcomes in advanced cancer and prevent the return of cancer in women diagnosed with higher-risk, early-stage, HER2-positive breast cancer. This study appears online in the journal Cancer, and will be published in a future print edition.

… Friday, June 24, 2011 Memorial Sloan Kettering Cancer Center physician-scientists report that women with small, node-negative, HER2 -positive breast cancer may obtain a significant benefit from adjuvant chemotherapy with trastuzumab (Herceptin ® ), a drug previously shown to improve outcomes in advanced

Learn how MSK’s Antibiotic Management Program is leading the way in ensuring that antibiotics and other antimicrobial drugs are used responsibly.

… Wednesday, May 22, 2019 Summary In this Q & A, infectious disease expert Susan Seo discusses MSK’s Antibiotic Management Program. It ensures that antibiotics and other antimicrobial drugs are used responsibly. The rapid emergence of drug-resistant microorganisms is “a global crisis that threatens a century